10/10 MannKind Is A Trade Not An Investment; •MannKind is moving up, but we still don’t consider it a strong investment. •Imfinzi MAA was accepted for Stage III lung cancer. •Onconova's rigosertib is progressing well. https://seekingalpha.com/article/4112686-daily-pharma-scoop-mannkind-trade-investment-astrazenecas-imfinzi?auth_param=1vat:1ctpqf0:fac82bba8ca11e5c55095f60991c4816&uprof=51